LifeStance Health Group (LFST) to Announce Earnings on Thursday

LifeStance Health Group (NASDAQ:LFST) is expected to be announcing its Q2 2026 results before the market opens on Thursday, August 6th. Analysts expect LifeStance Health Group to post earnings of $0.0328 per share and revenue of $414.5840 million for the quarter. Investors can check the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Thursday, August 6, 2026 at 8:30 AM ET.

LifeStance Health Group (NASDAQ:LFST) last released its quarterly earnings results on Wednesday, May 6th. The company reported $0.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.01 by $0.03. The firm had revenue of $403.48 million for the quarter, compared to the consensus estimate of $387.46 million. LifeStance Health Group had a return on equity of 1.56% and a net margin of 1.55%.The company’s quarterly revenue was up 21.2% compared to the same quarter last year. On average, analysts expect LifeStance Health Group to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

LifeStance Health Group Trading Up 0.6%

LFST opened at $10.54 on Tuesday. The company has a quick ratio of 1.48, a current ratio of 1.48 and a debt-to-equity ratio of 0.18. LifeStance Health Group has a 52 week low of $3.79 and a 52 week high of $11.76. The business’s 50 day moving average is $9.72 and its two-hundred day moving average is $7.97. The firm has a market cap of $4.09 billion, a price-to-earnings ratio of 175.67 and a beta of 1.14.

Analysts Set New Price Targets

LFST has been the topic of a number of recent research reports. Wall Street Zen cut shares of LifeStance Health Group from a “strong-buy” rating to a “buy” rating in a report on Saturday, July 25th. The Goldman Sachs Group initiated coverage on shares of LifeStance Health Group in a research report on Friday, June 5th. They set a “neutral” rating and a $9.00 price objective on the stock. BTIG Research lifted their price objective on shares of LifeStance Health Group from $12.00 to $15.00 and gave the company a “buy” rating in a research note on Friday, July 24th. Weiss Ratings reiterated a “hold (c-)” rating on shares of LifeStance Health Group in a research note on Wednesday, May 27th. Finally, Canaccord Genuity Group raised their price target on LifeStance Health Group from $11.00 to $13.00 and gave the stock a “buy” rating in a report on Tuesday, July 21st. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $11.50.

Insider Buying and Selling

In related news, Director Darren M. Black sold 5,899,661 shares of the stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $8.02, for a total transaction of $47,315,281.22. Following the completion of the sale, the director directly owned 23,310,115 shares of the company’s stock, valued at $186,947,122.30. This trade represents a 20.20% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Eric Shuey sold 243,362 shares of the company’s stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $8.02, for a total transaction of $1,951,763.24. Following the transaction, the director owned 867,562 shares of the company’s stock, valued at approximately $6,957,847.24. The trade was a 21.91% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 7,687,394 shares of company stock valued at $63,579,701 over the last three months. 3.50% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in LFST. California State Teachers Retirement System lifted its stake in shares of LifeStance Health Group by 1.6% during the fourth quarter. California State Teachers Retirement System now owns 125,682 shares of the company’s stock valued at $885,000 after buying an additional 1,966 shares during the period. Vident Advisory LLC grew its stake in LifeStance Health Group by 12.7% in the 2nd quarter. Vident Advisory LLC now owns 21,732 shares of the company’s stock worth $112,000 after acquiring an additional 2,447 shares during the period. Xponance LLC raised its holdings in LifeStance Health Group by 26.4% in the 4th quarter. Xponance LLC now owns 13,144 shares of the company’s stock valued at $93,000 after acquiring an additional 2,745 shares during the last quarter. Legal & General Group Plc boosted its holdings in shares of LifeStance Health Group by 2.4% during the second quarter. Legal & General Group Plc now owns 144,263 shares of the company’s stock worth $746,000 after purchasing an additional 3,331 shares during the last quarter. Finally, Polar Capital Holdings Plc boosted its holdings in shares of LifeStance Health Group by 19.3% during the third quarter. Polar Capital Holdings Plc now owns 21,775 shares of the company’s stock worth $120,000 after purchasing an additional 3,525 shares during the last quarter. 85.50% of the stock is owned by hedge funds and other institutional investors.

LifeStance Health Group Company Profile

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.